Aflac Incorporated (NYSE:AFL – Get Free Report) EVP Steven Kent Beaver sold 7,387 shares of the stock in a transaction on Friday, February 20th. The stock was sold at an average price of $113.58, for a total transaction of $839,015.46. Following the completion of the sale, the executive vice president directly owned 40,526 shares of the company’s stock, valued at $4,602,943.08. The trade was a 15.42% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Steven Kent Beaver also recently made the following trade(s):
- On Friday, December 12th, Steven Kent Beaver sold 5,492 shares of Aflac stock. The stock was sold at an average price of $109.53, for a total transaction of $601,538.76.
- On Friday, December 5th, Steven Kent Beaver sold 3,452 shares of Aflac stock. The shares were sold at an average price of $109.26, for a total value of $377,165.52.
Aflac Trading Up 0.1%
NYSE:AFL opened at $112.48 on Wednesday. Aflac Incorporated has a 12 month low of $96.95 and a 12 month high of $119.32. The business’s 50-day moving average is $111.37 and its two-hundred day moving average is $109.88. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.11 and a quick ratio of 0.11. The firm has a market capitalization of $58.95 billion, a PE ratio of 16.35, a price-to-earnings-growth ratio of 3.67 and a beta of 0.67.
Analyst Ratings Changes
AFL has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. raised their price target on shares of Aflac from $101.00 to $105.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Raymond James Financial restated an “outperform” rating and set a $119.00 target price (up from $110.00) on shares of Aflac in a research note on Tuesday, December 30th. Evercore boosted their price target on Aflac from $110.00 to $111.00 and gave the stock an “underperform” rating in a research note on Friday, November 7th. Weiss Ratings reissued a “buy (b+)” rating on shares of Aflac in a report on Monday, December 22nd. Finally, Barclays set a $101.00 price objective on Aflac and gave the stock an “underweight” rating in a report on Thursday, January 8th. Three research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $110.91.
Read Our Latest Research Report on Aflac
Institutional Trading of Aflac
Several institutional investors and hedge funds have recently bought and sold shares of AFL. Astoria Portfolio Advisors LLC. grew its position in shares of Aflac by 10.2% in the 4th quarter. Astoria Portfolio Advisors LLC. now owns 3,814 shares of the financial services provider’s stock worth $429,000 after acquiring an additional 353 shares in the last quarter. Pacer Advisors Inc. raised its position in shares of Aflac by 16.2% during the 4th quarter. Pacer Advisors Inc. now owns 45,045 shares of the financial services provider’s stock valued at $4,967,000 after acquiring an additional 6,295 shares in the last quarter. Kera Capital Partners Inc. bought a new position in Aflac during the fourth quarter worth $264,000. MV Capital Management Inc. acquired a new position in Aflac in the fourth quarter worth $470,000. Finally, Compound Planning Inc. increased its stake in Aflac by 2.6% during the fourth quarter. Compound Planning Inc. now owns 13,652 shares of the financial services provider’s stock valued at $1,505,000 after purchasing an additional 347 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.
Aflac Company Profile
Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.
Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.
Featured Articles
- Five stocks we like better than Aflac
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- This makes me furious
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
